NASDAQ: INBXV - Inhibrx, Inc.

Altı ay boyunca karlılık: 0%
Temettü getirisi: 0.00%
Sektör: Нефтегаз

Promosyon programı Inhibrx, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında Inhibrx, Inc.

Inhibrx, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidate includes INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency.

daha fazla ayrıntı
It also develops INBRX-109, a tetravalent therapeutic candidate targeting death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, colorectal cancer, ewing sarcoma, and pancreatic adenocarcinoma; and INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company has license and collaboration agreements with 2seventy bio, Inc. and Bristol-Myers Squibb Company. Inhibrx, Inc. was incorporated in 2009 and is headquartered in La Jolla, California.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2024-05-28
Валюта usd
Сайт https://inhibrx.com
Цена ао 30.85
Günlük fiyat değişimi: 0% (30.85)
Haftalık fiyat değişimi: 0% (30.85)
Aylık fiyat değişimi: 0% (30.85)
3 ayda fiyat değişimi: 0% (30.85)
Altı ayda fiyat değişimi: 0% (30.85)
Yılbaşından bu yana fiyat değişimi: 0% (30.85)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Toplam: 2.5

Yeterlik

İsim Anlam Seviye
ROA, % 0 0
ROE, % 0 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA 0 10
Toplam: 10

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 0 0
karlılık Ebitda, % 0 0
karlılık EPS, % 0 0
Toplam: 0
Daha fazla ayrıntı



Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Mark Paul Lappe Founder, Chairman, President & CEO 1967 (58 yıllar)
Dr. Brendan P. Eckelman Ph.D. Founder & Chief Scientific Officer 1979 (46 yıllar)
Mr. Quinn L. Deveraux Founder
Dr. Ashraf Amanullah Executive VP & Chief Technical Operations Officer 1968 (57 yıllar)
Ms. Leah Pollema J.D. VP, Corporate Secretary & General Counsel
Dr. Charbel Helaihel Pharm.D. Vice President of Marketing & Commercial Planning
Mr. Jeffrey J. Jensen Executive VP & Chief Clinical Operations Officer
Mr. David Matly M.B.A. Executive VP and Chief Commercial & Business Development Officer
Dr. Carlos Bais Ph.D. Executive Vice President of Translational Sciences
Dr. Josep Garcia Ph.D. EVP & Chief Clinical Development Officer

Adres: United States, La Jolla, 11025 North Torrey Pines Road - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://inhibrx.com